Oral Solid Dosage Contract Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the global Oral Solid Dosage Contract Manufacturing Market, offering an in-depth assessment of key market dynamics, including growth drivers, emerging trends, opportunities, and restraints. The report delivers a detailed view of the evolving market landscape, enabling pharmaceutical stakeholders, CDMOs, and investors to make informed strategic decisions.

Key Insights:

Oral Solid Dosage Contract Manufacturing Market Size (2025E): US$ 38.0 Bn
Projected Market Value (2032F): US$ 57.9 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 6.2%

Oral Solid Dosage Contract Manufacturing Market - Report Scope:

The oral solid dosage contract manufacturing market includes outsourced manufacturing services for solid pharmaceutical dosage forms such as tablets, capsules, softgels, powders, and granules. These services span across formulation development, scale-up, commercial manufacturing, packaging, and labeling. Oral solid dosage forms remain the most preferred route of drug administration due to their stability, ease of handling, patient compliance, and cost-effectiveness. The growing trend among pharmaceutical and biopharmaceutical companies to outsource manufacturing operations, coupled with increasing drug approvals and lifecycle management strategies, is significantly driving market growth. Advancements in modified-release technologies, high-potency drug manufacturing, and regulatory-compliant facilities further strengthen the market outlook during the forecast period.

Market Growth Drivers:

The growth of the global oral solid dosage contract manufacturing market is primarily driven by the rising outsourcing trend among pharmaceutical and biopharmaceutical companies seeking cost optimization and operational efficiency. Increasing drug development activities, particularly for generic drugs and complex formulations, have accelerated the demand for specialized contract manufacturing organizations with advanced capabilities. The expanding geriatric population and the growing prevalence of chronic diseases have led to higher consumption of oral solid dosage forms, further supporting market expansion. Additionally, the need for faster time-to-market, stringent regulatory requirements, and limited in-house manufacturing capacities are encouraging companies to rely on experienced contract manufacturers, thereby fueling sustained market growth.

Market Restraints:

Despite robust growth prospects, the oral solid dosage contract manufacturing market faces several challenges that may hinder its expansion. Strict regulatory compliance requirements across different regions increase operational complexity and cost for contract manufacturers. Dependence on pharmaceutical sponsors for long-term contracts can lead to revenue volatility, especially in cases of project delays or cancellations. Furthermore, rising competition among contract manufacturing organizations has resulted in pricing pressure, affecting profit margins. Capacity constraints and challenges related to technology transfer and quality assurance may also limit the growth potential for smaller and mid-sized players.

Market Opportunities:

The oral solid dosage contract manufacturing market presents significant opportunities driven by the increasing demand for complex and value-added dosage forms such as controlled-release and delayed-release formulations. The rapid growth of emerging and virtual pharmaceutical companies, which heavily depend on outsourcing partners, creates substantial opportunities for contract manufacturers. Expansion into nutraceutical and gummy dosage manufacturing is opening new revenue streams. Moreover, growing pharmaceutical production in emerging regions such as South Asia, East Asia, and Latin America, along with investments in advanced manufacturing technologies and continuous manufacturing processes, is expected to unlock long-term growth opportunities for market participants.

Competitive Analysis:

Key players operating in the global oral solid dosage contract manufacturing market include:

Recipharm
Aenova Holding
Catalent
AbbVie
Patheon N.V. (Thermo Fisher Scientific)
NextPharma
Lonza Group AG
Merck KGaA
Aurobindo Pharma Limited
Siegfried AG
Piramal Pharma Solutions
Corden Pharma
HERMES PHARMA GmbH
Medipaams India Private Limited
Alpex Pharma
Abaris Healthcare Pvt Ltd
Ardena Holdings N.V
Aphena Pharma Solutions
Actiza Pharmaceutical Private Limited
Sunwin Healthcare PVT. LTD
Kosher Pharmaceuticals
Boehringer Ingelheim BioXcellence

Oral Solid Dosage Contract Manufacturing Market Segmentation

By Dosage Form:

Tablets
Capsules
Softgels
Powders
Granules
Gummies
Others

By Mechanism:

Immediate Release
Delayed Release
Controlled Release

By Application:

Drug Product Development
Fill & Finish Product Manufacturing
Packaging / Labelling
Others

By End User:

Pharmaceutical Companies
Biopharmaceutical Companies
Emerging/Virtual Pharma Companies
Nutraceutical Companies

By Region:

North America
Europe
East Asia
South Asia and Oceania
Middle East and Africa
Latin America

Product Code: PMRREP25768

1. Executive Summary

1.1. Global Oral Solid Dosage Contract Manufacturing Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Oral Solid Dosage Contract Manufacturing Market Outlook:

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Dosage Form
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019 - 2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
  - 4.3.3.1. Tablets
  - 4.3.3.2. Capsules
  - 4.3.3.3. Softgels
  - 4.3.3.4. Powders
  - 4.3.3.5. Granules
  - 4.3.3.6. Gummies
  - 4.3.3.7. Others
- 4.3.4. Market Attractiveness Analysis: Dosage Form
4.4. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Mechanism
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Mechanism, 2019 - 2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
  - 4.4.3.1. Immediate Release
  - 4.4.3.2. Delayed Release
  - 4.4.3.3. Controlled Release
- 4.4.4. Market Attractiveness Analysis: Mechanism
4.5. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
  - 4.5.3.1. Drug Product Development
  - 4.5.3.2. Fill & Finish Product Manufacturing
  - 4.5.3.3. Packaging /Labelling
  - 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: Application
4.6. Global Oral Solid Dosage Contract Manufacturing Market Outlook: End User
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2024
- 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
  - 4.6.3.1. Pharmaceutical Companies
  - 4.6.3.2. Biopharmaceutical Companies
  - 4.6.3.3. Emerging/Virtual Pharma Companies
  - 4.6.3.4. Nutraceutical Companies
- 4.6.4. Market Attractiveness Analysis: End User

5. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Oral Solid Dosage Contract Manufacturing Market Outlook:

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 6.2.1. By Country
- 6.2.2. By Dosage Form
- 6.2.3. By Mechanism
- 6.2.4. By Application
- 6.2.5. By End User
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 6.4.1. Tablets
- 6.4.2. Capsules
- 6.4.3. Softgels
- 6.4.4. Powders
- 6.4.5. Granules
- 6.4.6. Gummies
- 6.4.7. Others
6.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 6.5.1. Immediate Release
- 6.5.2. Delayed Release
- 6.5.3. Controlled Release
6.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 6.6.1. Drug Product Development
- 6.6.2. Fill & Finish Product Manufacturing
- 6.6.3. Packaging /Labelling
- 6.6.4. Others
6.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 6.7.1. Pharmaceutical Companies
- 6.7.2. Biopharmaceutical Companies
- 6.7.3. Emerging/Virtual Pharma Companies
- 6.7.4. Nutraceutical Companies
6.8. Market Attractiveness Analysis

7. Europe Oral Solid Dosage Contract Manufacturing Market Outlook:

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 7.2.1. By Country
- 7.2.2. By Dosage Form
- 7.2.3. By Mechanism
- 7.2.4. By Application
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 7.4.1. Tablets
- 7.4.2. Capsules
- 7.4.3. Softgels
- 7.4.4. Powders
- 7.4.5. Granules
- 7.4.6. Gummies
- 7.4.7. Others
7.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 7.5.1. Immediate Release
- 7.5.2. Delayed Release
- 7.5.3. Controlled Release
7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 7.6.1. Drug Product Development
- 7.6.2. Fill & Finish Product Manufacturing
- 7.6.3. Packaging /Labelling
- 7.6.4. Others
7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 7.7.1. Pharmaceutical Companies
- 7.7.2. Biopharmaceutical Companies
- 7.7.3. Emerging/Virtual Pharma Companies
- 7.7.4. Nutraceutical Companies
7.8. Market Attractiveness Analysis

8. East Asia Oral Solid Dosage Contract Manufacturing Market Outlook:

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 8.2.1. By Country
- 8.2.2. By Dosage Form
- 8.2.3. By Mechanism
- 8.2.4. By Application
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 8.4.1. Tablets
- 8.4.2. Capsules
- 8.4.3. Softgels
- 8.4.4. Powders
- 8.4.5. Granules
- 8.4.6. Gummies
- 8.4.7. Others
8.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 8.5.1. Immediate Release
- 8.5.2. Delayed Release
- 8.5.3. Controlled Release
8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 8.6.1. Drug Product Development
- 8.6.2. Fill & Finish Product Manufacturing
- 8.6.3. Packaging /Labelling
- 8.6.4. Others
8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 8.7.1. Pharmaceutical Companies
- 8.7.2. Biopharmaceutical Companies
- 8.7.3. Emerging/Virtual Pharma Companies
- 8.7.4. Nutraceutical Companies
8.8. Market Attractiveness Analysis

9. South Asia & Oceania Oral Solid Dosage Contract Manufacturing Market Outlook:

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 9.2.1. By Country
- 9.2.2. By Dosage Form
- 9.2.3. By Mechanism
- 9.2.4. By Application
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 9.4.1. Tablets
- 9.4.2. Capsules
- 9.4.3. Softgels
- 9.4.4. Powders
- 9.4.5. Granules
- 9.4.6. Gummies
- 9.4.7. Others
9.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 9.5.1. Immediate Release
- 9.5.2. Delayed Release
- 9.5.3. Controlled Release
9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 9.6.1. Drug Product Development
- 9.6.2. Fill & Finish Product Manufacturing
- 9.6.3. Packaging /Labelling
- 9.6.4. Others
9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 9.7.1. Pharmaceutical Companies
- 9.7.2. Biopharmaceutical Companies
- 9.7.3. Emerging/Virtual Pharma Companies
- 9.7.4. Nutraceutical Companies
9.8. Market Attractiveness Analysis

10. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook:

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 10.2.1. By Country
- 10.2.2. By Dosage Form
- 10.2.3. By Mechanism
- 10.2.4. By Application
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 10.4.1. Tablets
- 10.4.2. Capsules
- 10.4.3. Softgels
- 10.4.4. Powders
- 10.4.5. Granules
- 10.4.6. Gummies
- 10.4.7. Others
10.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 10.5.1. Immediate Release
- 10.5.2. Delayed Release
- 10.5.3. Controlled Release
10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 10.6.1. Drug Product Development
- 10.6.2. Fill & Finish Product Manufacturing
- 10.6.3. Packaging /Labelling
- 10.6.4. Others
10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 10.7.1. Pharmaceutical Companies
- 10.7.2. Biopharmaceutical Companies
- 10.7.3. Emerging/Virtual Pharma Companies
- 10.7.4. Nutraceutical Companies
10.8. Market Attractiveness Analysis

11. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook:

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 11.2.1. By Country
- 11.2.2. By Dosage Form
- 11.2.3. By Mechanism
- 11.2.4. By Application
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Dosage Form, 2025 - 2032
- 11.4.1. Tablets
- 11.4.2. Capsules
- 11.4.3. Softgels
- 11.4.4. Powders
- 11.4.5. Granules
- 11.4.6. Gummies
- 11.4.7. Others
11.5. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025 - 2032
- 11.5.1. Immediate Release
- 11.5.2. Delayed Release
- 11.5.3. Controlled Release
11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
- 11.6.1. Drug Product Development
- 11.6.2. Fill & Finish Product Manufacturing
- 11.6.3. Packaging /Labelling
- 11.6.4. Others
11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 - 2032
- 11.7.1. Pharmaceutical Companies
- 11.7.2. Biopharmaceutical Companies
- 11.7.3. Emerging/Virtual Pharma Companies
- 11.7.4. Nutraceutical Companies
11.8. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2024
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Recipharm
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Aenova Holding
- 12.3.3. Catalent
- 12.3.4. AbbVie
- 12.3.5. Patheon N.V. (Thermo Fisher Scientific)
- 12.3.6. NextPharma
- 12.3.7. Lonza Group AG
- 12.3.8. Merck KGaA
- 12.3.9. Aurobindo Pharma Limited
- 12.3.10. Siegfried AG
- 12.3.11. Piramal Pharma Solutions
- 12.3.12. Corden Pharma
- 12.3.13. HERMES PHARMA GmbH
- 12.3.14. Medipaams India Private Limited
- 12.3.15. Alpex Pharma
- 12.3.16. Abaris Healthcare Pvt Ltd
- 12.3.17. Ardena Holdings N.V
- 12.3.18. Aphena Pharma Solutions
- 12.3.19. Actiza Pharmaceutical Private Limited
- 12.3.20. Sunwin Healthcare PVT. LTD
- 12.3.21. Kosher Pharmaceuticals
- 12.3.22. Boehringer Ingelheim BioXcellence
- 12.3.23. Others

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations